eurocognitive testing in children with ADHD
- Conditions
- Attention Deficit Hyperactivity DisorderMedDRA version: 9.1Level: LLTClassification code 10003735Term: Attention deficit-hyperactivity disorder
- Registration Number
- EUCTR2008-004425-42-NL
- Lead Sponsor
- Centre for Human Drug Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
•Written informed consent from parents having parental responsibility or from the legal guardian. In the case of a child aged 12 years the written informed consent of the child is needed in addition to that of parents having responsibility/legal guardian;
•Aged 8-12 years;
•Able to communicate with the investigator in Dutch;
•Confirmed DSM IV diagnosis of ADHD (Based on examination by a psychiatrist or pediatrician);
•Classifying as clinical ADHD on the AVL(ADHD Vragenlijst”);
•Currently receiving treatment with (immediate or sustained release) methylphenidate
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
•Use of drugs other than methylphenidate with known psychotropic effects.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method